СОВРЕМЕННЫЕ МЕТОДЫ ПРОФИЛАКТИКИ ИЗБЫТОЧНОГО РУБЦЕВАНИЯ

Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121(11): 2081-90. DOI: https://doi.org/10.1016/j.ophtha.2014.05.013

Saheb H., Ahmed, II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 2012; 23(2): 96-104. DOI: https://doi.org/10.1097/ICU.0b013e32834ff1e7

Fontana H., Nouri-Mahdavi K., Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol 2006; 141(4): 652-9. DOI: https://doi.org/10.1016/j.ajo.2005.11.039

Петров С.Ю., Вострухин С.В., Асламазова А.Э., Шерстнева Л.В. Современная микроинвазивная хирургия глауком. Вестник офтальмологии 2016; 132(3): 96-102.

Петров С.Ю., Сафонова Д.М. Современная концепция избыточного рубцевания в хирургии глаукомы. . Офтальмология 2015; 12(4): 9-17.

Broadway D.C., Grierson I., O'Brien C., Hitchings R.A. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994; 112(11): 1437-45. DOI: https://doi.org/10.1001/archopht.1994.01090230051020

Sherwood M.B., Grierson I., Millar L., Hitchings R.A. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology 1989; 96(3): 327-35. DOI: https://doi.org/10.1016/S0161-6420(89)32888-0

Baratz K.H., Nau C.B., Winter E.J., McLaren J.W., Hodge D.O., Herman D.C., et al. Effects of glaucoma medications on corneal endothelium, keratocytes, and subbasal nerves among participants in the ocular hypertension treatment study. Cornea 2006; 25(9): 1046-52. DOI: https://doi.org/10.1097/01.ico.0000230499.07273.c5

Noecker R.J., Herrygers L.A., Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 2004; 23(5): 490-6. DOI: https://doi.org/10.1097/01.ico.0000116526.57227.82

Baudouin C., Pisella P.J., Fillacier K., Goldschild M., Becquet F., De Saint Jean M., et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999; 106(3): 556-63. DOI: https://doi.org/10.1016/S0161-6420(99)90116-1

Broadway D.C., Grierson I., Sturmer J., Hitchings R.A. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 1996; 114(3): 262-7. DOI: https://doi.org/10.1001/archopht.1996.01100130258004

Cantrill H.L., Palmberg P.F., Zink H.A., Waltman S.R., Podos S.M., Becker B. Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure. Am J Ophthalmol 1975; 79(6): 1012-7. DOI: https://doi.org/10.1016/0002-9394(75)90687-X

Mindel J.S., Tavitian H.O., Smith H., Jr., Walker E.C. Comparative ocular pressure elevation by medrysone, fluorometholone, and dexamethasone phosphate. Arch Ophthalmol 1980; 98(9): 1577-8. DOI: https://doi.org/10.1001/archopht.1980.01020040429006

Roberti G., Oddone F., Agnifili L., Katsanos A., Michelessi M., Mastropasqua L., et al. Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management. Surv Ophthalmol 2020; 65(4): 458-72. DOI: https://doi.org/10.1016/j.survophthal.2020.01.002

Breusegem C., Spielberg L., Van Ginderdeuren R., Vandewalle E., Renier C., Van de Veire S., et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology 2010; 117(7): 1324-30. DOI: https://doi.org/10.1016/j.ophtha.2009.11.038

Iyer J.V., Zhao Y., Lim F.P.M., Tong L., Wong T.T.L. Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis. Clin Ophthalmol 2017; 11(1191-6. DOI: https://doi.org/10.2147/OPTH.S134570

Tailor R., Batra R., Mohamed S. A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface (.). Semin Ophthalmol 2016; 31(6): 519-25. DOI: https://doi.org/10.3109/08820538.2014.986585

Fan Gaskin J.C., Nguyen D.Q., Soon Ang G., O'Connor J., Crowston J.G. Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I). J Curr Glaucoma Pract 2014; 8(2): 37-45. DOI: https://doi.org/10.5005/jp-journals-10008-1159

Murdoch I. Post-operative management of trabeculectomy in the first three months. Community Eye Health 2012; 25(79-80): 73-5.

Furtado J.M., Paula J.S., Soares E.G., Lira R.C., Rocha A.M., Dhegaide N.H., et al. Perioperative conjunctival inflammation and trabeculectomy outcome. Ocul Immunol Inflamm 2014; 22(3): 183-8. DOI: https://doi.org/10.3109/09273948.2013.844263

Kuljaca Z., Jojic Z. [5-fluorouracil in the treatment of postoperative glaucoma]. Srp Arh Celok Lek 1996; 124(7-8): 190-2.

Nilforushan N., Yadgari M., Kish S.K., Nassiri N. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Am J Ophthalmol 2012; 153(2): 352-7 e1. DOI: https://doi.org/10.1016/j.ajo.2011.08.005

Sengupta S., Venkatesh R., Ravindran R.D. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. J Glaucoma 2012; 21(7): 450-9. DOI: https://doi.org/10.1097/IJG.0b013e31821826b2

Miller M.H., Rice N.S. Trabeculectomy combined with beta irradiation for congenital glaucoma. Br J Ophthalmol 1991; 75(10): 584-90. DOI: https://doi.org/10.1136/bjo.75.10.584

El Mazar H.M., Mandour S.S., Mostafa M.I., Elmorsy O.A. Augmented Subscleral Trabeculectomy With Beta Radiation and Mitomycin C in Egyptian Glaucoma Patients. J Glaucoma 2019; 28(7): 637-42. DOI: https://doi.org/10.1097/IJG.0000000000001255

Shah M., Foreman D.M., Ferguson M.W. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994; 107 ( Pt 5)(1137-57. DOI: https://doi.org/10.1242/jcs.107.5.1137

Schultheiss M., Schnichels S., Konrad E.M., Bartz-Schmidt K.U., Zahn G., Caldirola P., et al. alpha5beta1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model. Acta Ophthalmol 2017; 95(1): e1-e9. DOI: https://doi.org/10.1111/aos.13215

Van Bergen T., Zahn G., Caldirola P., Fsadni M., Caram-Lelham N., Vandewalle E., et al. Integrin alpha5beta1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery. Invest Ophthalmol Vis Sci 2016; 57(14): 6428-39. DOI: https://doi.org/10.1167/iovs.16-19751

Yang J., Shi L.K., Sun H.M., Wang Y.M. Antiproliferative effect of double suicide gene delivery mediated by polyamidoamine dendrimers in human Tenon's capsule fibroblasts. Exp Ther Med 2017; 14(6): 5473-9. DOI: https://doi.org/10.3892/etm.2017.5235

Wollensak G., Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA). Acta Ophthalmol 2009; 87(2): 193-8. DOI: https://doi.org/10.1111/j.1755-3768.2008.01229.x

Choi S., Lee S.C., Lee H.J., Cheong Y., Jung G.B., Jin K.H., et al. Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light. Lasers Med Sci 2013; 28(5): 1289-96. DOI: https://doi.org/10.1007/s10103-012-1237-6

Ge L.Y., Wu T.H., Liu Y.Q., Jiang C., Yin X. Management of experimental trabeculectomy filtering blebs via crosslinking of the scleral flap inhibited vascularization. Graefes Arch Clin Exp Ophthalmol 2024; 262(5): 1507-17. DOI: https://doi.org/10.1007/s00417-023-06306-8